Analysis of the effectiveness of laparoscopic myomectomy using a standardized technique

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: Uterine fibroids are a benign monoclonal tumor arising from myometrial smooth muscle cells and fibroblasts with the deposition of extracellular matrix components in response to vascular injury. Diagnosis of uterine fibroids is steadily growing every year due to the introduction of new and accessible research methods. At the moment, the preferred organ-preserving surgical method for treating uterine fibroids is laparoscopic myomectomy, which allows preserving reproductive function. Considering the high risk of intra- and postoperative bleeding during surgery, the development and use of blood-saving technologies remains relevant. This article contains results of the effectiveness of the surgical technique without performing the stage of vessel clipping, which involves assessing the volume of intraoperative blood loss and the duration of the operation.

AIM: The aim of this study was to analyze the effectiveness of using a standardized technique of laparoscopic myomectomy without uterine artery clipping.

MATERIALS AND METHODS: This study included 77 patients with symptomatic uterine fibroids who underwent surgical treatment in Gynecological Department I with Operating Unit, The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott (St. Petersburg, Russia). Implying an assessment of the volume of intraoperative blood loss and the duration of the operation.

RESULTS: The average number of removed myomatous nodes was 2.2 ± 1.2 (from 1 to 11). The size of the removed fibroids averaged 5.1 ± 1.8 cm in diameter. At the same time, the minimum size of the remote node was 1.5 cm, and the maximum size was 15 cm. Intramural [International Federation of Gynecology and Obstetrics (FIGO) types 3 and 4] localization of myomatous nodes was found in 30 (17.6%) cases, intramural subserosal (FIGO type 5) in 45 (26.4%) cases, subserosal (FIGO type 6) in 54 (31.7%) cases, subserosal pedunculated (FIGO type 7) in 30 (17.6%) cases, and intramural submucosal and submucosal forms (FIGO types 0–2) in ten (5.8 %) cases. The average intraoperative blood loss was 187.7 ± 16.71 ml, average hemoglobin level in the postoperative period was 117.1 ± 13.15 g/l, with an initial level of 126 ± 12.1 g/l. The average duration of the operation was 95 ± 30.3 minutes, and the average bed-day was 8 ± 1.5.

CONCLUSIONS: The data obtained allow for drawing a reasonable conclusion about the effectiveness and safety of the standardized technique of laparoscopic myomectomy, developed in Gynecological Department I with Operating Unit, The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott (Saint Petersburg, Russia), and for recommending its widespread use.

全文:

受限制的访问

作者简介

Nikolai Polenov

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

编辑信件的主要联系方式.
Email: polenovdoc@mail.ru
ORCID iD: 0000-0001-8575-7026
SPIN 代码: 9387-1703

MD, Cand. Sci. (Medicine)

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034

Maria Dolgikh

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: mariadolgikh1@gmail.com
ORCID iD: 0000-0002-9910-9668
SPIN 代码: 3879-7773

MD

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034

Maria Yarmolinskaya

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147
SPIN 代码: 3686-3605

MD, Dr. Sci. (Medicine), Professor, Professor of the Russian Academy of Sciences

俄罗斯联邦, 3 Mendeleevskaya Line, Saint Petersburg, 199034

参考

  1. Holdsworth-Carson SJ, Zaitseva M, Vollenhoven BJ, et al. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. MHR: Basic science of reproductive medicine. 2014;20(3):250–259. doi: 10.1093/molehr/gat083
  2. Stewart E, Cookson C, Gandolfo R, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512. doi: 10.1111/1471-0528.14640
  3. Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):96–102. doi: 10.1016/j.ejogrb.2010.05.012
  4. Al-Hendy A, Myers E, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(06):473–480. doi: 10.1055/s-0037-1607264
  5. Yuk JS, Kim M. Incidence rates of myomectomy-related mortality and venous thromboembolism in South Korea: a population-based study. Front Med. 2022;9:1–7. doi: 10.3389/fmed.2022.849660
  6. Abuladze DA. On the issue of the preserving method of surgery for the removal of interstitial and submucosal uterine fibromyomas by means of glandular section. Journal of Obstetrics and Women’s Diseases. 1901;15(7–8):1117–1164.
  7. Bhave Chittawar P, Franik S, Pouwer AW, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014(10):1–62. doi: 10.1002/14651858.CD004638.pub3
  8. Mukunda SB, Shen Y, Sugandha S. Benefits and limitations of laparoscopic myomectomy. Open J Obstet Gynecol. 2019;9(3):292–301. doi: 10.4236/ojog.2019.93030
  9. Giannini A, Cuccu I, D’Auge TG, et al. The great debate: surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon. Eur J Obstet Gynecol Reprod Biol. 2024;297:50–58. doi: 10.1016/j.ejogrb.2024.03.045
  10. Barakat EE, Bedaiwy MA, Zimberg S, et al. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2):256–266. doi: 10.1097/AOG.0b013e318207854f
  11. Bezhenar VF, Tsypurdeeva AA, Dolinskiy AK, et al. The experience of a standardized technique of laparoscopic myomectomy. Journal of Obstetrics and Women’s Diseases. 2012;61(4):23–32. EDN: QBGFDX doi: 10.17816/JOWD61423-32
  12. Holub Z, Jabor A, Lukac J, et al. Laparoscopic myomectomy with lateral dissection of the uterine artery. JSLS. 2005;9(4):447–453.
  13. Vercellino G, Erdemoglu E, Joe A, et al. Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy. Arch Gynecol Obstet. 2012;286(5):1181–1186. doi: 10.1007/s00404-012-2419-y
  14. Liu WM, Tzeng CR, Yi-Jen C, et al. Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids. Fertil Steril. 2004;82(1):205–210. doi: 10.1016/j.fertnstert.2004.01.026
  15. Dubuisson J, Ramyead L, Streuli I. The role of preventive uterine artery occlusion during laparoscopic myomectomy: a review of the literature. Arch Gynecol Obstet. 2015;291(4):737–743. doi: 10.1007/s00404-014-3546-4
  16. Liu WM, Wang PH, Chou CS, et al. Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas. Fertil Steril. 2007;87(2):356–361. doi: 10.1016/j.fertnstert.2006.07.1497
  17. Alborzi S, Ghannadan E, Alborzi S, et al. A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma. Fertil Steril. 2009;92(2):742–747. doi: 10.1016/j.fertnstert.2008.06.011
  18. Liu L, Li Y, Xu H, et al. Laparoscopic transient uterine artery occlusion and myomectomy for symptomatic uterine myoma. Fertil Steril. 2011;95(1):254–258. doi: 10.1016/j.fertnstert.2010.05.006
  19. Kwon YS, Cho YM, Im KS, et al. Transient occlusion of uterine arteries in procedures with high risk of uterine bleeding. JSLS. 2019;23(1):1–5. doi: 10.4293/JSLS.2018.00072
  20. Bae JH, Chong GO, Seong WJ, et al. Benefit of uterine artery ligation in laparoscopic myomectomy. Fertil Steril. 2011;95(2):775–778. doi: 10.1016/j.fertnstert.2010.07.1079
  21. Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 2014;2014(7):1–91. doi: 10.1002/14651858.CD005355.pub5
  22. Kim HS, Paxton BE, Lee JM. Long-term efficacy and safety of uterine artery embolization in young patients with and without uteroovarian anastomoses. J Vasc Interv Radiol. 2008;19(2):195–200. doi: 10.1016/j.jvir.2007.08.014
  23. Aryutin DG. Uterine artery embolization in patients with uterine blood supply, taking into account the features of the pelvic organs [dissertation]. Moscow; 2011. 26 p. EDN: QESUCJ (In Russ.)
  24. Farrer-Brown G, Beilby JOW, Tarbit MH. The blood supply of the uterus. BJOG. 1970;77(8):673–681. doi: 10.1111/j.1471-0528.1970.tb03592.x
  25. Aran T, Guven S, Unsal MA, et al. Serum ischemia-modified albumin as a novel marker of ovarian torsion: an experimental study. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):72–75. doi: 10.1016/j.ejogrb.2010.01.006

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Intramural localization of the myomatous node (FIGO types 3 and 4), 8 cm in size

下载 (96KB)
索引源数据
3. Fig. 2. Subserosal fibroids on a broad base (FIGO type 7), 7 cm in size

下载 (127KB)
索引源数据
4. Fig. 3. Atypical localization of the myomatous node (FIGO type 8), 9 cm in size

下载 (149KB)
索引源数据
5. Fig. 4. Subserosal fibroids (FIGO type 6), 15 cm in size

下载 (114KB)
索引源数据
6. Fig. 5. Double-layer interrupted uterine suture after myomectomy

下载 (195KB)
索引源数据

版权所有 © Eсо-Vector, 2024

许可 URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389 от 15.07.2002 г.